Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8SNC | M1H2Q1 | Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer | |
| 8SNC | 8SNC | Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer | |
| 8SMT | 8SMT | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMT | P0DTC2 | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMN | P13563 | Xenopus laevis hyaluronan synthase 1, nascent HA polymer bound state | |
| 8SMN | 8SMN | Xenopus laevis hyaluronan synthase 1, nascent HA polymer bound state | |
| 8SMI | P0DTC2 | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMI | 8SMI | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8SM2 | H9H2V9 | Crystal Structure of the macaque FcalphaRI bound to macaque IgA Fc. | |
| 8SM2 | G7NN72 | Crystal Structure of the macaque FcalphaRI bound to macaque IgA Fc. | |
| 8SM1 | P03200 | CRYSTAL STRUCTURE OF HUMAN ANTIBODY 769A9 IN COMPLEX WITH EPSTEIN-BARR VIRUS MAJOR GLYCOPROTEIN GP350 | |
| 8SM1 | 8SM1 | CRYSTAL STRUCTURE OF HUMAN ANTIBODY 769A9 IN COMPLEX WITH EPSTEIN-BARR VIRUS MAJOR GLYCOPROTEIN GP350 | |
| 8SM0 | P20023 | Crystal structure of human complement receptor 2 (CD21) in complex with Epstein-Barr virus major glycoprotein gp350 | |
| 8SM0 | P03200 | Crystal structure of human complement receptor 2 (CD21) in complex with Epstein-Barr virus major glycoprotein gp350 | |
| 8SLV | P13080 | Structure of a salivary alpha-glucosidase from the mosquito vector Aedes aegypti. | |
| 8SL1 | Q9BXP8 | Cryo-EM structure of PAPP-A2 | |
| 8SKV | P01876 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
| 8SKV | P01833 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
| 8SKV | P01591 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
| 8SKV | P13050 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
| 8SKU | P01876 | Structure of human SIgA1 in complex with human CD89 (FcaR1) | |
| 8SKU | P01833 | Structure of human SIgA1 in complex with human CD89 (FcaR1) | |
| 8SKU | P01591 | Structure of human SIgA1 in complex with human CD89 (FcaR1) | |
| 8SKU | P24071 | Structure of human SIgA1 in complex with human CD89 (FcaR1) | |
| 8SK7 | A4GCK8 | Cryo-EM structure of designed Influenza HA binder, HA_20, bound to Influenza HA (Strain: Iowa43) | |
| 8SK7 | 8SK7 | Cryo-EM structure of designed Influenza HA binder, HA_20, bound to Influenza HA (Strain: Iowa43) | |
| 8SK5 | P0DTC2 | Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain | |
| 8SK5 | 8SK5 | Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain | |
| 8SJK | 8SJK | Pembrolizumab Caffeine crystal | |
| 8SJ9 | A0A0G2RXV5 | Crystal structure of the H1 hemagglutinin COBRA X6 | |
| 8SIT | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SIT | 8SIT | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SIS | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIS | 8SIS | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIE | A0A8D0Z6H8 | Pendrin in complex with bicarbonate | |
| 8SID | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | 8SID | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SIC | 8SIC | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SIC | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SI9 | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | 8SI9 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SGW | A0A8D0Z6H8 | Pendrin in complex with chloride |
